|
FR3053244A1
|
|
Device for delivery of at least one active principle by permucosal mouth.
|
|
FR3031668A1
|
|
DEVICE FOR DELIVERY OF ACTIVE PRINCIPLE BY PERMUCOSAL MOUTH.
|
|
FR3000896A1
|
|
Galenic form for administration of active ingredient (s) for accelerated induction of sleep and / or treatment of sleep disorders
|
|
FR2967894A1
|
|
Device for packaging, preserving and extending preparation of one or more active principles (s).
|
|
WO2010063978A1
|
|
Device for packaging and delivering active principles in a hydroalcoholic solution
|
|
FR2947729A1
|
|
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TYPE II DIABETES BY ORAL TRANS-MUCOSAL METHOD
|
|
FR2940911A1
|
|
Formulation for oral transmucosal administration of antalgic and / or anti-spasmodic molecules
|
|
FR2940116A1
|
|
FORMULATION FOR THE ADMINISTRATION OF HYPOLIPEMIC BY ORAL TRANS-MUCOSAL
|
|
FR2940120A1
|
|
FORMULATION FOR TRANSMUCOSAL DELIVERY OF SETRONS
|
|
FR2930140A1
|
|
Device for storing, extended preparation and administration of a low assay of active ingredient
|
|
FR2926721A1
|
|
Galenic form for transmucosal administration of triptans
|
|
FR2918874A1
|
|
Device for conditioning and administering sub-lingual of active principles
|
|
FR2910317A1
|
|
Galenic form for transmucal administration of paracetamol
|
|
FR2906140A1
|
|
Galenic form for transmucosus administration of active ingredients
|
|
EP1711162A1
|
|
Composition for use in the local treatment of oropharyngeal conditions comprising ibuprofen or ketoprofen
|
|
US2008241120A1
|
|
Use of Pilocarpine For Hypoptyalism Treatment
|
|
FR2649611A1
|
|
Process for preparing a dosage form of a therapeutic composition, in particular one based on aspirin
|
|
FR2621823A1
|
|
Improvement in methods and devices for blood self-transfusion
|
|
EP0311721A1
|
|
Plastic composition for the protection of body surfaces, and device for its use
|
|
FR2600535A1
|
|
New composition based on lysozyme and papaine for hygiene and the comfort of the oral cavity.
|
